BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38633631)

  • 21. Circulating serum exosomal
    Lu X; Lu J; Wang S; Zhang Y; Ding Y; Shen X; Jing R; Ju S; Chen H; Cong H
    Future Oncol; 2021 Mar; 17(8):907-919. PubMed ID: 33533649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic implication of downregulated exosomal miRNAs in patients with sepsis: a cross-sectional study with bioinformatics analysis.
    Shin B; Lee JY; Im Y; Yoo H; Park J; Lee JS; Lee KY; Jeon K
    J Intensive Care; 2023 Aug; 11(1):35. PubMed ID: 37537685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integration of LC-LTQ-Orbitrap-MS and Network Pharmacology to Analyze the Active Components of Sijunzi Decoction and their Mechanism of Action Against Cytotoxicity-associated Premature Ovarian Insufficiency.
    Chen Y; Han S; Kang A; Fu R; Chen L; Guo J; Wang Q
    Comb Chem High Throughput Screen; 2023; 26(14):2437-2451. PubMed ID: 36872360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-151a-3p-rich small extracellular vesicles derived from gastric cancer accelerate liver metastasis via initiating a hepatic stemness-enhancing niche.
    Li B; Xia Y; Lv J; Wang W; Xuan Z; Chen C; Jiang T; Fang L; Wang L; Li Z; He Z; Li Q; Xie L; Qiu S; Zhang L; Zhang D; Xu H; Xu Z
    Oncogene; 2021 Oct; 40(43):6180-6194. PubMed ID: 34535770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chinmedomics facilitated quality-marker discovery of Sijunzi decoction to treat spleen qi deficiency syndrome.
    Zhao Q; Gao X; Yan G; Zhang A; Sun H; Han Y; Li W; Liu L; Wang X
    Front Med; 2020 Jun; 14(3):335-356. PubMed ID: 31749036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant expression profiles and bioinformatic analysis of CAF-derived exosomal miRNAs from three moderately differentiated supraglottic LSCC patients.
    Wu C; Wang M; Huang Q; Guo Y; Gong H; Hu C; Zhou L
    J Clin Lab Anal; 2022 Jan; 36(1):e24108. PubMed ID: 34788477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exo-miR-144-3p as a promising diagnostic biomarker for depressive symptoms in heart failure.
    Wang R; Huang K; Feng Y; Duan J; Ying H; Shi Q; Zhang Y; Jiang R; Yang L
    Neurobiol Dis; 2024 Mar; 192():106415. PubMed ID: 38266934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mir-605-3p prevents liver premetastatic niche formation by inhibiting angiogenesis via decreasing exosomal nos3 release in gastric cancer.
    Hu Y; Zang W; Feng Y; Mao Q; Chen J; Zhu Y; Xue W
    Cancer Cell Int; 2024 May; 24(1):184. PubMed ID: 38802855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sijunzi decoction enhances sensitivity of colon cancer cells to NK cell destruction by modulating P53 expression.
    Wang X; Pan S; Chen L; Liang C; Zhu Y; Zhou K; Shi X
    J Ethnopharmacol; 2024 Jul; 329():118115. PubMed ID: 38580190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomal small RNA sequencing uncovers the microRNA dose markers for power frequency electromagnetic field exposure.
    Li H; Lin L; Li L; Zhou L; Zhang Y; Hao S; Ding Z
    Biomarkers; 2018; 23(4):315-327. PubMed ID: 29297241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma-derived exosomal let-7c-5p, miR-335-3p, and miR-652-3p as potential diagnostic biomarkers for stable coronary artery disease.
    Han J; Cui X; Yuan T; Yang Z; Liu Y; Ren Y; Wu C; Bian Y
    Front Physiol; 2023; 14():1161612. PubMed ID: 37228823
    [No Abstract]   [Full Text] [Related]  

  • 32. MicroRNA sequence analysis of plasma exosomes in early Legg-CalvĂ©-Perthes disease.
    Huang Q; Li B; Lin C; Chen X; Wang T; Liu J; Liu Y; Lu R; Liao S; Ding X
    Cell Signal; 2022 Mar; 91():110184. PubMed ID: 34740784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sijunzi decoction ameliorates gastric precancerous lesions via regulating oxidative phosphorylation based on proteomics and metabolomics.
    Zhu Y; Ma R; Cheng W; Qin M; Guo W; Qi Y; Dai J
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116925. PubMed ID: 37467821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
    He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
    Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening of Serum Exosomal miRNAs as Diagnostic Biomarkers for Gastric Cancer Using Small RNA Sequencing.
    Wang JF; Jiang YM; Zhan WH; Ye SP; Li TY; Zhang JN
    J Oncol; 2022; 2022():5346563. PubMed ID: 35571485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression profile of plasma exosomal microRNAs in women with polycystic ovary syndrome.
    Jiang X; Li J; Zhang B; Hu J; Ma J; Cui L; Chen ZJ
    Fertil Steril; 2021 Mar; 115(3):782-792. PubMed ID: 33041053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
    Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
    J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of serum exosomal miR-98-5p, miR-183-5p, miR-323-3p and miR-19b-3p as potential biomarkers for glioblastoma patients and investigation of their mechanisms.
    Yang Q; Wei B; Peng C; Wang L; Li C
    Curr Res Transl Med; 2022 Jan; 70(1):103315. PubMed ID: 34837760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells.
    Zhang S; Zhang X; Fu X; Li W; Xing S; Yang Y
    Oncol Lett; 2018 Aug; 16(2):2391-2401. PubMed ID: 30013629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential Expression of Serum Exosomal Hsa-miR-487b-3p in Progressive Vitiligo Before and After Systemic Corticosteroid Treatment.
    Luo H; Xie B; Xu J; Zhu Y; Sun J; Shen Y; Song X
    Clin Cosmet Investig Dermatol; 2022; 15():1377-1386. PubMed ID: 35880009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.